Cite
HARVARD Citation
Ostenfeld, T. et al. (2015). A Randomized, Placebo-controlled Trial of the Analgesic Efficacy and Safety of the p38 MAP Kinase Inhibitor, Losmapimod, in Patients With Neuropathic Pain From Lumbosacral Radiculopathy. Clinical journal of pain. 31 (4), p. . [Online].